Program
Bupivacaine
Also written as “HTX-011”, “SKY0402” and “Bupivacaine HCl”.
Its studies are mostly in Pain, Postoperative · Pain · Hernia, Inguinal · Bunion · Hemorrhoids, led by 10 companies.
Drug pageBupivacaine: every studyMany companies study it; this page follows only the 56 they lead. All 1,200 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Pacira BioSciencesits history only | 230 open or running | phase 4since Oct 24, 2011 | Jun 11, 2007 | none ahead |
| Heron Therapeuticsits history only | 171 open or running | phase 4since Oct 10, 2018 | Jun 9, 2015 | none ahead |
| Innocollits history only | 60 open or running | phase 3since Aug 12, 2015 | Oct 18, 2010 | none ahead |
| Bausch Health Companiesits history only | 20 open or running | phase 3since Oct 9, 2015 | Mar 30, 2010 | none ahead |
| Cristália Produtos Químicos Farmacêuticos Ltda.its history only | 20 open or running | phase 3since Feb 23, 2011 | Feb 23, 2011 | none ahead |
| Jiangsu HengRui Medicineits history only | 22 open or running | phase 4since Mar 13, 2024 | Mar 13, 2024 | Nov 2026phase 2 · NCT06529432 |
| Ascension Healthits history only | 10 open or running | phase 3since Nov 20, 2019 | Nov 20, 2019 | none ahead |
| Liquidia Technologiesits history only | 10 open or running | phase 1since Nov 22, 2016 | Nov 22, 2016 | none ahead |
| Rebel Medicineits history only | 11 open or running | phase 2since Apr 28, 2026 | Apr 28, 2026 | none ahead |
| Tian Medicalits history only | 10 open or running | phase 4since Oct 16, 2012 | Oct 16, 2012 | none ahead |
Also a collaborator on its studies: Pfizer, Premier Research Group and Richmond Pharmacology.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of every company. Pick one to see its own:
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 41 studies since Jun 11, 2007.
- Apr 17, 2019Phase 2 study in AgnosiaHeron Therapeutics · NCT03922048
- May 9, 2019Phase 2 study in Pain, PostoperativeHeron Therapeutics · NCT03955211 · 25 enrolled · United States
- Jun 3, 2019Phase 3 study in AgnosiaHeron Therapeutics · NCT03974932 · 116 enrolled · United States
- Jun 25, 2019Phase 1 study in BunionPacira BioSciences · NCT04002089 · 45 enrolled · United States
- Nov 20, 2019Ascension Health’s first study: phase 3 study in AgnosiaNew to Ascension HealthAscension Health · NCT04173312 · 120 enrolled · United States
- Aug 4, 2020Phase 3 study in BunionPacira BioSciences · NCT04518462 · 121 enrolled · United States
- Mar 1, 20212 phase 3 studies in Pain, PostoperativeInnocoll · NCT04785638, NCT04785625
- May 27, 2021Phase 2 study in Pain, PostoperativeHeron Therapeutics · NCT04911062 · 32 enrolled · United States
- Oct 1, 2021Phase 4 study in AgnosiaHeron Therapeutics · NCT05109312 · 90 enrolled · United States
- Oct 25, 20232 phase 4 studies in Pain, PostoperativeHeron Therapeutics · NCT06109428, NCT06109415
- Mar 13, 2024Jiangsu HengRui Medicine’s first study: phase 4 study in Local Analgesia Via InfiltrationNew to Jiangsu HengRui MedicineJiangsu HengRui Medicine · NCT06344091 · 232 planned · China
- Jul 26, 2024Phase 2 study in Local Analgesia Via Nerve BlockJiangsu HengRui Medicine · NCT06529432 · 96 planned · China
- Apr 28, 2026Rebel Medicine’s first study: phase 2 study in Hallux ValgusNew to Rebel MedicineRebel Medicine · NCT07574385 · 60 planned · United States
- Sep 28, 2026Primary completion moved from 2026-09-28 to 2027-05Date moved laterphase 4 · +8 months · NCT06344091
Ahead
- Nov 2026Primary completion: phase 2 study in Local Analgesia Via Nerve BlockJiangsu HengRui Medicine · NCT06529432
- May 2027Primary completion: phase 4 study in Local Analgesia Via InfiltrationJiangsu HengRui Medicine · NCT06344091
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 56 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07574385Hallux Valgus · United States | 2 | Recruiting | Rebel Medicine | Aug 2026 | 60 |
| NCT06529432Local Analgesia Via Nerve Block · China | 2 | Recruiting | Jiangsu HengRui Medicine | Nov 2026 | 96 |
| NCT06344091Local Analgesia Via Infiltration · China | 4 | Recruiting | Jiangsu HengRui Medicine | May 2027 | 232 |
| NCT06109428Pain, Postoperative · United States | 4 | Completed | Heron Therapeutics | Mar 29, 2022 | 37 |
| NCT06109415Pain, Postoperative · United States | 4 | Completed | Heron Therapeutics | Jul 18, 2022 | 30 |
| NCT05109312Agnosia · United States | 4 | Active, not recruiting | Heron Therapeutics | Jun 2024 | 90 |
| NCT04911062Pain, Postoperative · United States | 2 | Completed | Heron Therapeutics | Jul 29, 2022 | 32 |
| NCT04785638Pain, Postoperative · United States | 3 | Completed | Innocoll | Jan 10, 2023 | 100 |
| NCT04785625Pain, Postoperative · United States | 3 | Completed | Innocoll | Oct 27, 2021 | 366 |
| NCT04518462Bunion · United States | 3 | Completed | Pacira BioSciences | Apr 5, 2021 | 121 |
| NCT04173312Agnosia · United States | 3 | UNKNOWN | Ascension Health | Jan 2023 | 120 |
| NCT04002089Bunion · United States | 1 | Completed | Pacira BioSciences | Dec 2, 2019 | 45 |
| NCT03974932Agnosia · United States | 3 | Completed | Heron Therapeutics | Dec 7, 2020 | 116 |
| NCT03955211Pain, Postoperative · United States | 2 | Completed | Heron Therapeutics | Dec 3, 2021 | 25 |
| NCT03922048Agnosia | 2 | Withdrawn | Heron Therapeutics | Nov 2025 | 0 |
| NCT03907176Agnosia · United States | 3 | Completed | Heron Therapeutics | Oct 25, 2021 | 209 |
| NCT03718039Pain, Postoperative · United States | 2 | Completed | Heron Therapeutics | Jan 31, 2019 | 78 |
| NCT03705065Pain, Postoperative · United States | 4 | Completed | Heron Therapeutics | Oct 8, 2018 | 30 |
| NCT03695367Pain, Postoperative · United States | 2 | Completed | Heron Therapeutics | Nov 20, 2018 | 63 |
| NCT03295721Pain, Postoperative · United States | 3 | Completed | Heron Therapeutics | Jan 8, 2018 | 412 |
| NCT03262688Hernia, Inguinal · United States | 3 | UNKNOWN | Innocoll | Jan 31, 2024 | 159 |
| NCT03237481Pain, Postoperative · United States, Belgium | 3 | Completed | Heron Therapeutics | Dec 22, 2017 | 418 |
| NCT03015532Pain, Postoperative · United States | 2 | Completed | Heron Therapeutics | Apr 20, 2018 | 285 |
| NCT03011333Pain, Postoperative · United States | 2 | Completed | Heron Therapeutics | Feb 1, 2018 | 243 |
| NCT02982889Acute Pain · Denmark | 1 | Completed | Liquidia Technologies | Mar 23, 2017 | 29 |
| NCT02713490Pain · United States | 4 | Completed | Pacira BioSciences | Feb 8, 2017 | 140 |
| NCT02574520Pain, Postoperative · United States | 3 | Completed | Bausch Health Companies | Jun 2017 | 399 |
| NCT02525133Pain, Postoperative · United States | 3 | Completed | Innocoll | Apr 22, 2016 | 319 |
| NCT02523599Pain, Postoperative · United States | 3 | Completed | Innocoll | Apr 2016 | 305 |
| NCT02517905Toothache · United States | 3 | Completed | Pacira BioSciences | Jan 2016 | 166 |
| NCT02504580Pain, Postoperative · United States | 2 | Completed | Heron Therapeutics | Mar 2017 | 463 |
| NCT02471898Agnosia · United States | 2 | Completed | Heron Therapeutics | Sep 2015 | 71 |
| NCT02284386Pain · United States | 4 | Completed | Pacira BioSciences | Mar 2015 | 15 |
| NCT02255500Pain · United States | 4 | Completed | Pacira BioSciences | Mar 2015 | 23 |
| NCT02142829Obesity · United States | 4 | Completed | Pacira BioSciences | Mar 2013 | 101 |
| NCT01709708Migraine Disorders · United States | 4 | Completed | Tian Medical | Feb 2014 | 41 |
| NCT01507220Intestinal Obstruction · United States | 4 | Terminated | Pacira BioSciences | Jul 2012 | 2 |
| NCT01308047Fracture of Lower Limb · Brazil | 3 | Withdrawn | Cristália Produtos Químicos Farmacêuticos Ltda. | 0 | |
| NCT01303107Cesarean Delivery · Brazil | 3 | Withdrawn | Cristália Produtos Químicos Farmacêuticos Ltda. | 0 | |
| NCT01224145Hernia · United States | 2 | Completed | Innocoll | Jun 20, 2011 | 10 |
| NCT01206608Pain, Postoperative · United States | 2 | Completed | Pacira BioSciences | Aug 2008 | 40 |
| NCT01206595Pain, Postoperative | 2 | Completed | Pacira BioSciences | Mar 2006 | 58 |
| NCT01203644Hernia, Inguinal | 2 | Completed | Pacira BioSciences | Jan 2006 | 76 |
| NCT01096966Chronic Low Back Pain · United States | 2 | Completed | Bausch Health Companies | Feb 2011 | 263 |
| NCT00890721Hemorrhoids · Poland | 3 | Completed | Pacira BioSciences | Nov 2009 | 189 |
| NCT00890682Bunion · United States | 3 | Completed | Pacira BioSciences | Nov 2009 | 193 |
| NCT00813111Pain · United States | 3 | Terminated | Pacira BioSciences | Feb 2009 | 136 |
| NCT00812305Pain · Poland | 1 | Completed | Pacira BioSciences | Aug 2009 | 16 |
| NCT00807209Pain, Postoperative · United States | 2 | Terminated | Pacira BioSciences | Feb 2009 | 3 |
| NCT00806806Agnosia · United States | 1 | Completed | Pacira BioSciences | Feb 2009 | 128 |
| NCT00745290Pain, Postoperative · United States | 3 | Completed | Pacira BioSciences | Jan 2009 | 245 |
| NCT00744848Hemorrhoids · United States | 3 | Completed | Pacira BioSciences | Feb 2009 | 204 |
| NCT00529126Pain, Postoperative · United States, Georgia | 2 | Completed | Pacira BioSciences | Dec 2007 | 100 |
| NCT00485693Pain, Postoperative · United States, Czechia | 2 | Completed | Pacira BioSciences | Aug 2009 | 138 |
| NCT00485667Pain, Postoperative · United Kingdom | 1 | Completed | Pacira BioSciences | Aug 2007 | 48 |
| NCT00485433Pain, Postoperative · United States | 2 | Completed | Pacira BioSciences | Dec 2007 | 98 |
How it is read
Names in the registry
- “HTX-011”, 20 entries
- “SKY0402”, 12 entries
- “Bupivacaine HCl”, 7 entries
- “Bupivacaine”, 5 entries
- “Bupivacaine Liposome Injection”, 2 entries
Conditions, from the studies’ own filings
- Pain, Postoperative, 27 studies
- Pain, 5 studies
- Hernia, Inguinal, 4 studies
- Bunion, 3 studies
- Hemorrhoids, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.